NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS
申请人:Du Pont Pharmaceuticals Company
公开号:EP1054877A1
公开(公告)日:2000-11-29
[EN] NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS<br/>[FR] NOUVEAUX SULFAMIDES CYCLIQUES UTILISES COMME INHIBITEURS DES METALLOPROTEASES
申请人:DU PONT PHARMACEUTICALS COMPANY
公开号:WO1999041246A1
公开(公告)日:1999-08-19
(EN) The present application describes novel lactams and derivatives thereof of formula (I) or pharmaceutically acceptable salt forms thereof, wherein ring B is a 4-8 membered cyclic sulfonamide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.(FR) L'invention concerne de nouveaux lactames, leurs dérivés et leurs sels pharmaceutiquement acceptables, de formule (I), dans laquelle le noyau B est un sulfamide cyclique constitué de 4 à 8 éléments renfermant 0 à 3 hétéroatomes supplémentaires choisis entre N, O et S. Ces composés sont utiles comme inhibiteurs des métalloprotéases.
Reductive Arylation of Aliphatic and Aromatic Aldehydes with Cyanoarenes by Electrolysis for the Synthesis of Alcohols
An electroreductive arylation reaction of aliphatic and aromaticaldehydes as well as ketones with electro-deficient (hetero)arenes is described. A variety of cyano(hetero)arenes and carbonyl compounds, especially aliphatic aldehydes, have been examined, providing secondary and tertiary alcohols in moderate to good yields. Mechanistic studies, including cyclic voltammetry (CV), electron paramagnetic